> top > docs > PubMed:26646445 > annotations

PubMed:26646445 JSONTXT

Annnotations TAB JSON ListView MergeView

Glycan-Motif

Id Subject Object Predicate Lexical cue
T1 632-639 https://glytoucan.org/Structures/Glycans/G00051MO denotes Lewis X

GlyCosmos6-Glycan-Motif-Image

Id Subject Object Predicate Lexical cue image
T1 632-639 Glycan_Motif denotes Lewis X https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G01187XC|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00051MO

Glycosmos6-GlycoEpitope

Id Subject Object Predicate Lexical cue
T1 632-639 http://www.glycoepitope.jp/epitopes/EP0011 denotes Lewis X

GlyCosmos6-Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 632-639 https://glytoucan.org/Structures/Glycans/G00051MO denotes Lewis X

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-98 Sentence denotes Elevated level of serum glycoprotein bifucosylation and prognostic value in Chinese breast cancer.
TextSentencer_T2 99-167 Sentence denotes Aberrant glycosylation is highly associated with cancer progression.
TextSentencer_T3 168-409 Sentence denotes The aim of this study was to compare bifucosylated N-glycans in sera obtained from healthy controls and breast cancer patients, with the goal of identifying a potential indicator for monitoring the recurrence and metastasis of breast cancer.
TextSentencer_T4 410-549 Sentence denotes A unique structural pattern of bifucosylated N-glycan, with both core and antennary fucosylation, was identified in breast cancer patients.
TextSentencer_T5 550-689 Sentence denotes The spectrum of antennary fucosylation was a composite of the standard spectra of Lewis X and H2, indicating a mixture of the two epitopes.
TextSentencer_T6 690-999 Sentence denotes Permethylated N-glycans of the glycoproteins extracted from 91 breast cancer patients and 43 healthy controls were detected using linear ion-trap quadrupole-electrospray ionization mass spectrometry, which appeared to be a highly sensitive and useful approach in the detection and identification of N-glycans.
TextSentencer_T7 1000-1185 Sentence denotes To evaluate MS profile data, several statistical tools were applied, including Student's t-test, partial least squares discriminant analysis and receiver-operating characteristic curve.
TextSentencer_T8 1186-1337 Sentence denotes The results showed that the measurement of bifucosylation degree and CEA levels had an improved diagnostic performance compared with that of CEA alone.
TextSentencer_T9 1338-1501 Sentence denotes We compared the potential of bifucosylated N-glycan as an indicator of breast cancer recurrence with the current clinical biomarkers, i.e., CEA, CA 15-3 and CA125.
TextSentencer_T10 1502-1668 Sentence denotes The result revealed that, compared with CEA, CA 15-3 and CA125, the bifucosylation degree of N-glycans could be a more reliable indicator of breast cancer recurrence.
T1 0-98 Sentence denotes Elevated level of serum glycoprotein bifucosylation and prognostic value in Chinese breast cancer.
T2 99-167 Sentence denotes Aberrant glycosylation is highly associated with cancer progression.
T3 168-409 Sentence denotes The aim of this study was to compare bifucosylated N-glycans in sera obtained from healthy controls and breast cancer patients, with the goal of identifying a potential indicator for monitoring the recurrence and metastasis of breast cancer.
T4 410-549 Sentence denotes A unique structural pattern of bifucosylated N-glycan, with both core and antennary fucosylation, was identified in breast cancer patients.
T5 550-689 Sentence denotes The spectrum of antennary fucosylation was a composite of the standard spectra of Lewis X and H2, indicating a mixture of the two epitopes.
T6 690-999 Sentence denotes Permethylated N-glycans of the glycoproteins extracted from 91 breast cancer patients and 43 healthy controls were detected using linear ion-trap quadrupole-electrospray ionization mass spectrometry, which appeared to be a highly sensitive and useful approach in the detection and identification of N-glycans.
T7 1000-1185 Sentence denotes To evaluate MS profile data, several statistical tools were applied, including Student's t-test, partial least squares discriminant analysis and receiver-operating characteristic curve.
T8 1186-1337 Sentence denotes The results showed that the measurement of bifucosylation degree and CEA levels had an improved diagnostic performance compared with that of CEA alone.
T9 1338-1501 Sentence denotes We compared the potential of bifucosylated N-glycan as an indicator of breast cancer recurrence with the current clinical biomarkers, i.e., CEA, CA 15-3 and CA125.
T10 1502-1668 Sentence denotes The result revealed that, compared with CEA, CA 15-3 and CA125, the bifucosylation degree of N-glycans could be a more reliable indicator of breast cancer recurrence.
T1 0-98 Sentence denotes Elevated level of serum glycoprotein bifucosylation and prognostic value in Chinese breast cancer.
T2 99-167 Sentence denotes Aberrant glycosylation is highly associated with cancer progression.
T3 168-409 Sentence denotes The aim of this study was to compare bifucosylated N-glycans in sera obtained from healthy controls and breast cancer patients, with the goal of identifying a potential indicator for monitoring the recurrence and metastasis of breast cancer.
T4 410-549 Sentence denotes A unique structural pattern of bifucosylated N-glycan, with both core and antennary fucosylation, was identified in breast cancer patients.
T5 550-689 Sentence denotes The spectrum of antennary fucosylation was a composite of the standard spectra of Lewis X and H2, indicating a mixture of the two epitopes.
T6 690-999 Sentence denotes Permethylated N-glycans of the glycoproteins extracted from 91 breast cancer patients and 43 healthy controls were detected using linear ion-trap quadrupole-electrospray ionization mass spectrometry, which appeared to be a highly sensitive and useful approach in the detection and identification of N-glycans.
T7 1000-1185 Sentence denotes To evaluate MS profile data, several statistical tools were applied, including Student's t-test, partial least squares discriminant analysis and receiver-operating characteristic curve.
T8 1186-1337 Sentence denotes The results showed that the measurement of bifucosylation degree and CEA levels had an improved diagnostic performance compared with that of CEA alone.
T9 1338-1501 Sentence denotes We compared the potential of bifucosylated N-glycan as an indicator of breast cancer recurrence with the current clinical biomarkers, i.e., CEA, CA 15-3 and CA125.
T10 1502-1668 Sentence denotes The result revealed that, compared with CEA, CA 15-3 and CA125, the bifucosylation degree of N-glycans could be a more reliable indicator of breast cancer recurrence.

GlycoBiology-FMA

Id Subject Object Predicate Lexical cue
_T1 18-23 FMAID:167330 denotes serum
_T2 24-36 FMAID:167256 denotes glycoprotein
_T3 24-36 FMAID:62925 denotes glycoprotein
_T4 84-90 FMAID:97486 denotes breast
_T5 84-90 FMAID:9601 denotes breast
_T6 272-278 FMAID:97486 denotes breast
_T7 272-278 FMAID:9601 denotes breast
_T8 395-401 FMAID:97486 denotes breast
_T9 395-401 FMAID:9601 denotes breast
_T10 526-532 FMAID:9601 denotes breast
_T11 526-532 FMAID:97486 denotes breast
_T12 595-604 FMAID:50603 denotes composite
_T13 595-604 FMAID:146309 denotes composite
_T14 721-734 FMAID:62925 denotes glycoproteins
_T15 721-734 FMAID:167256 denotes glycoproteins
_T16 753-759 FMAID:9601 denotes breast
_T17 753-759 FMAID:97486 denotes breast
_T18 1091-1095 FMAID:178661 denotes test
_T19 1409-1415 FMAID:97486 denotes breast
_T20 1409-1415 FMAID:9601 denotes breast
_T21 1643-1649 FMAID:9601 denotes breast
_T22 1643-1649 FMAID:97486 denotes breast

uniprot-human

Id Subject Object Predicate Lexical cue
T1 831-835 http://www.uniprot.org/uniprot/Q9UFF0 denotes trap
T2 1012-1014 http://www.uniprot.org/uniprot/Q99707 denotes MS
T3 1255-1258 http://www.uniprot.org/uniprot/P06731 denotes CEA
T4 1327-1330 http://www.uniprot.org/uniprot/P06731 denotes CEA
T5 1478-1481 http://www.uniprot.org/uniprot/P06731 denotes CEA
T6 1542-1545 http://www.uniprot.org/uniprot/P06731 denotes CEA
T7 1483-1490 http://www.uniprot.org/uniprot/Q9BXA4 denotes CA 15-3
T8 1547-1554 http://www.uniprot.org/uniprot/Q9BXA4 denotes CA 15-3
T9 1495-1500 http://www.uniprot.org/uniprot/Q8WXI7 denotes CA125
T10 1559-1564 http://www.uniprot.org/uniprot/Q8WXI7 denotes CA125

uniprot-mouse

Id Subject Object Predicate Lexical cue
T1 831-835 http://www.uniprot.org/uniprot/Q05117 denotes trap
T2 831-835 http://www.uniprot.org/uniprot/Q8K1H1 denotes trap
T3 1012-1014 http://www.uniprot.org/uniprot/A6H5Y3 denotes MS

GlycoBiology-NCBITAXON

Id Subject Object Predicate Lexical cue
T1 91-97 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T2 99-107 http://purl.bioontology.org/ontology/NCBITAXON/317910 denotes Aberrant
T3 148-154 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T4 279-285 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T5 402-408 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T6 484-493 http://purl.bioontology.org/ontology/NCBITAXON/293542 denotes antennary
T7 533-539 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T8 566-575 http://purl.bioontology.org/ontology/NCBITAXON/293542 denotes antennary
T9 760-766 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T10 1255-1258 http://purl.bioontology.org/ontology/NCBITAXON/1107390 denotes CEA
T11 1327-1330 http://purl.bioontology.org/ontology/NCBITAXON/1107390 denotes CEA
T12 1416-1422 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer
T13 1478-1481 http://purl.bioontology.org/ontology/NCBITAXON/1107390 denotes CEA
T14 1542-1545 http://purl.bioontology.org/ontology/NCBITAXON/1107390 denotes CEA
T15 1650-1656 http://purl.bioontology.org/ontology/NCBITAXON/6754 denotes cancer

GO-BP

Id Subject Object Predicate Lexical cue
T1 108-121 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T2 232-236 http://purl.obolibrary.org/obo/GO_0004617 denotes sera
T3 494-506 http://purl.obolibrary.org/obo/GO_0036065 denotes fucosylation
T4 576-588 http://purl.obolibrary.org/obo/GO_0036065 denotes fucosylation
T5 920-929 http://purl.obolibrary.org/obo/GO_0046960 denotes sensitive
T6 1255-1258 http://purl.obolibrary.org/obo/GO_0033848 denotes CEA
T7 1327-1330 http://purl.obolibrary.org/obo/GO_0033848 denotes CEA
T8 1478-1481 http://purl.obolibrary.org/obo/GO_0033848 denotes CEA
T9 1542-1545 http://purl.obolibrary.org/obo/GO_0033848 denotes CEA
T10 1483-1485 http://purl.obolibrary.org/obo/GO_0033968 denotes CA
T11 1547-1549 http://purl.obolibrary.org/obo/GO_0033968 denotes CA

GO-CC

Id Subject Object Predicate Lexical cue
T1 475-479 http://purl.obolibrary.org/obo/GO_0019013 denotes core

UBERON-AE

Id Subject Object Predicate Lexical cue
T1 18-23 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum
T2 84-90 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T3 272-278 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T4 395-401 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T5 526-532 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T6 753-759 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T7 1409-1415 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
T8 1643-1649 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast

GlycoBiology-Motifs

Id Subject Object Predicate Lexical cue
T1 219-228 http://rdf.glycoinfo.org/glycan/G00027MO denotes N-glycans
T2 704-713 http://rdf.glycoinfo.org/glycan/G00027MO denotes N-glycans
T3 989-998 http://rdf.glycoinfo.org/glycan/G00027MO denotes N-glycans
T4 455-463 http://rdf.glycoinfo.org/glycan/G00027MO denotes N-glycan
T5 1381-1389 http://rdf.glycoinfo.org/glycan/G00027MO denotes N-glycan
T6 632-637 http://rdf.glycoinfo.org/glycan/G00047MO denotes Lewis
T7 632-639 http://rdf.glycoinfo.org/glycan/G00051MO denotes Lewis X

Lectin

Id Subject Object Predicate Lexical cue
Lectin_T1 1483-1485 https://acgg.asia/db/lfdb/LfDB0227 denotes CA
Lectin_T2 1547-1549 https://acgg.asia/db/lfdb/LfDB0227 denotes CA

GlycoBiology-Epitope

Id Subject Object Predicate Lexical cue
PD-GlycoEpitope-B_T1 632-639 http://www.glycoepitope.jp/epitopes/EP0011 denotes Lewis X

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 84-90 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T2 272-278 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T3 395-401 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T4 526-532 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T5 753-759 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T6 1409-1415 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T7 1643-1649 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T8 18-23 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T1 84-97 Disease denotes breast cancer http://purl.obolibrary.org/obo/MONDO_0007254
T2 148-154 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T3 272-285 Disease denotes breast cancer http://purl.obolibrary.org/obo/MONDO_0007254
T4 395-408 Disease denotes breast cancer http://purl.obolibrary.org/obo/MONDO_0007254
T5 526-539 Disease denotes breast cancer http://purl.obolibrary.org/obo/MONDO_0007254
T6 753-766 Disease denotes breast cancer http://purl.obolibrary.org/obo/MONDO_0007254
T7 1409-1422 Disease denotes breast cancer http://purl.obolibrary.org/obo/MONDO_0007254
T8 1643-1656 Disease denotes breast cancer http://purl.obolibrary.org/obo/MONDO_0007254

GlyCosmos15-Glycan

Id Subject Object Predicate Lexical cue image
T1 632-639 Glycan denotes Lewis X https://api.glycosmos.org/wurcs2image/latest/png/binary/G00051MO

HP-phenotype

Id Subject Object Predicate Lexical cue hp_id
T1 84-97 Phenotype denotes breast cancer HP:0003002
T2 148-154 Phenotype denotes cancer HP:0002664
T3 272-285 Phenotype denotes breast cancer HP:0003002
T4 395-408 Phenotype denotes breast cancer HP:0003002
T5 526-539 Phenotype denotes breast cancer HP:0003002
T6 753-766 Phenotype denotes breast cancer HP:0003002
T7 913-929 Phenotype denotes highly sensitive HP:0041092
T8 1409-1422 Phenotype denotes breast cancer HP:0003002
T9 1643-1656 Phenotype denotes breast cancer HP:0003002

Glycan-GlyCosmos

Id Subject Object Predicate Lexical cue image
T1 632-639 Glycan denotes Lewis X https://api.glycosmos.org/wurcs2image/latest/png/binary/G00051MO

GlyCosmos-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 632-639 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes Lewis X http://www.glycoepitope.jp/epitopes/EP0011

GlyCosmos15-HP

Id Subject Object Predicate Lexical cue hp_id
T1 84-97 Phenotype denotes breast cancer HP:0003002
T2 148-154 Phenotype denotes cancer HP:0002664
T3 272-285 Phenotype denotes breast cancer HP:0003002
T4 395-408 Phenotype denotes breast cancer HP:0003002
T5 526-539 Phenotype denotes breast cancer HP:0003002
T6 753-766 Phenotype denotes breast cancer HP:0003002
T7 913-929 Phenotype denotes highly sensitive HP:0041092
T8 1409-1422 Phenotype denotes breast cancer HP:0003002
T9 1643-1656 Phenotype denotes breast cancer HP:0003002

GlyCosmos15-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 84-90 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T2 272-278 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T3 395-401 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T4 526-532 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T5 753-759 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T6 1409-1415 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T7 1643-1649 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310

GlyCosmos15-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 84-97 Disease denotes breast cancer MONDO:0004989|MONDO:0007254
T3 148-154 Disease denotes cancer MONDO:0004992
T4 272-285 Disease denotes breast cancer MONDO:0004989|MONDO:0007254
T6 395-408 Disease denotes breast cancer MONDO:0004989|MONDO:0007254
T8 526-539 Disease denotes breast cancer MONDO:0004989|MONDO:0007254
T10 753-766 Disease denotes breast cancer MONDO:0004989|MONDO:0007254
T12 1409-1422 Disease denotes breast cancer MONDO:0004989|MONDO:0007254
T14 1643-1656 Disease denotes breast cancer MONDO:0004989|MONDO:0007254

GlyCosmos15-Taxon

Id Subject Object Predicate Lexical cue db_id
T1 286-294 Organism denotes patients 9606
T2 540-548 Organism denotes patients 9606
T3 767-775 Organism denotes patients 9606

GlyCosmos15-Sentences

Id Subject Object Predicate Lexical cue
T1 0-98 Sentence denotes Elevated level of serum glycoprotein bifucosylation and prognostic value in Chinese breast cancer.
T2 99-167 Sentence denotes Aberrant glycosylation is highly associated with cancer progression.
T3 168-409 Sentence denotes The aim of this study was to compare bifucosylated N-glycans in sera obtained from healthy controls and breast cancer patients, with the goal of identifying a potential indicator for monitoring the recurrence and metastasis of breast cancer.
T4 410-549 Sentence denotes A unique structural pattern of bifucosylated N-glycan, with both core and antennary fucosylation, was identified in breast cancer patients.
T5 550-689 Sentence denotes The spectrum of antennary fucosylation was a composite of the standard spectra of Lewis X and H2, indicating a mixture of the two epitopes.
T6 690-999 Sentence denotes Permethylated N-glycans of the glycoproteins extracted from 91 breast cancer patients and 43 healthy controls were detected using linear ion-trap quadrupole-electrospray ionization mass spectrometry, which appeared to be a highly sensitive and useful approach in the detection and identification of N-glycans.
T7 1000-1185 Sentence denotes To evaluate MS profile data, several statistical tools were applied, including Student's t-test, partial least squares discriminant analysis and receiver-operating characteristic curve.
T8 1186-1337 Sentence denotes The results showed that the measurement of bifucosylation degree and CEA levels had an improved diagnostic performance compared with that of CEA alone.
T9 1338-1501 Sentence denotes We compared the potential of bifucosylated N-glycan as an indicator of breast cancer recurrence with the current clinical biomarkers, i.e., CEA, CA 15-3 and CA125.
T10 1502-1668 Sentence denotes The result revealed that, compared with CEA, CA 15-3 and CA125, the bifucosylation degree of N-glycans could be a more reliable indicator of breast cancer recurrence.

GlyCosmos15-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 632-639 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes Lewis X http://www.glycoepitope.jp/epitopes/EP0011

GlyCosmos15-FMA

Id Subject Object Predicate Lexical cue db_id
T1 18-23 Body_part denotes serum FMA:63083
T2 84-90 Body_part denotes breast FMA:9601
T3 272-278 Body_part denotes breast FMA:9601
T4 395-401 Body_part denotes breast FMA:9601
T5 526-532 Body_part denotes breast FMA:9601
T6 753-759 Body_part denotes breast FMA:9601
T7 1409-1415 Body_part denotes breast FMA:9601
T8 1643-1649 Body_part denotes breast FMA:9601

Anatomy-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 84-90 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T2 272-278 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T3 395-401 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T4 526-532 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T5 753-759 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T6 1409-1415 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310
T7 1643-1649 Body_part denotes breast http://purl.obolibrary.org/obo/UBERON_0000310